Literature DB >> 8450081

Metronidazole in the treatment of localized juvenile periodontitis.

L Saxén1, S Asikainen.   

Abstract

Systemic metronidazole and tetracycline were compared as adjunctive agents in the treatment of localized juvenile periodontitis (LJP). 27 patients with Actinobacillus actinomycetemcomitans-positive (Aa) LJP were treated with scaling and rootplaning, control of oral hygiene and periodontal surgery if indicated. The patients were randomly divided into 3 equal groups: the 1st group had metronidazole 200 mg x 3 x 10 days, the 2nd tetracycline 250 mg x 4 x 12 days, the 3rd group received no medication and served as a control. 6 patients had periodontal surgery. 4 sites with the most advanced bone loss as determined on radiographs were selected in each subject for test sites. Gingival index, gingival bleeding after probing (GB), probing depth (PD), suppuration, and radiographic bone loss were registered, and subgingival Aa was selectively cultured. GB and PD > or = 4 mm were registered in the whole dentition as well. All parameters were monitored at baseline and at 6 and 18 months after treatment. By the end of the study, Aa was suppressed to below detection level at all test sites only in the metronidazole group, at 17/26 sites (4 patients) in the tetracycline group and at 19/26 sites (6 patients) in the control group. Clinically, all groups showed improvement. In conclusion, metronidazole was more effective than tetracycline in the suppression of Aa and the suppression of Aa appeared to produce better clinical results.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450081     DOI: 10.1111/j.1600-051x.1993.tb00339.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  9 in total

1.  Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.

Authors:  En Hyung Chang; Peter Giaquinto; Joanne Huang; Nataliya V Balashova; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2019-12-26       Impact factor: 3.563

Review 2.  Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.

Authors:  W J Loesche; N S Grossman
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 3.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

4.  Catechin-mediated restructuring of a bacterial toxin inhibits activity.

Authors:  En Hyung Chang; Joanne Huang; Zixiang Lin; Angela C Brown
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-10-17       Impact factor: 3.770

5.  Receptor-Based Peptides for Inhibition of Leukotoxin Activity.

Authors:  Eric Krueger; Shannon Hayes; En Hyung Chang; Shailagne Yutuc; Angela C Brown
Journal:  ACS Infect Dis       Date:  2018-05-17       Impact factor: 5.084

6.  Aggregatibacter actinomycetemcomitans Leukotoxin Is Delivered to Host Cells in an LFA-1-Indepdendent Manner When Associated with Outer Membrane Vesicles.

Authors:  Justin B Nice; Nataliya V Balashova; Scott C Kachlany; Evan Koufos; Eric Krueger; Edward T Lally; Angela C Brown
Journal:  Toxins (Basel)       Date:  2018-10-13       Impact factor: 4.546

7.  Cranberry Proanthocyanidins Neutralize the Effects of Aggregatibacter actinomycetemcomitans Leukotoxin.

Authors:  Amel Ben Lagha; Amy Howell; Daniel Grenier
Journal:  Toxins (Basel)       Date:  2019-11-14       Impact factor: 4.546

8.  Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm.

Authors:  Orit Oettinger-Barak; Stuart G Dashper; Deanne V Catmull; Geoffrey G Adams; Michael N Sela; Eli E Machtei; Eric C Reynolds
Journal:  J Oral Microbiol       Date:  2013-05-08       Impact factor: 5.474

Review 9.  Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis.

Authors:  Dorte Haubek; Anders Johansson
Journal:  J Oral Microbiol       Date:  2014-08-14       Impact factor: 5.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.